Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector Minyan Zhu Current Opinion Open access 14 August 2021 Pages: 561 - 576
gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance Susan O’ConnellMegan DaleGrace Carolan-Rees Review Article Open access 28 July 2021 Pages: 577 - 586
Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses Liv SolvĂĄr NymarkAlex MillerAnna Vassall Systematic Review Open access 04 May 2021 Pages: 587 - 603
Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review Tamás ZeleiNicholas D. MendolaJonathan D. Campbell Systematic Review Open access 18 May 2021 Pages: 605 - 612
Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic Review Annemieke Oude Lansink-HartgringOlivier van Minnenthe Dutch Extracorporeal Life Support Study Group Systematic Review Open access 31 May 2021 Pages: 613 - 623
Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States Ash Bullement Emma S. KnowlesRon Preblick Original Research Article Open access 15 July 2021 Pages: 625 - 633
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile Manuel Antonio EspinozaRubén RojasCarlos Balmaceda Original Research Article Open access 05 July 2021 Pages: 635 - 647
Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan Robin L. CorelliThanh G. TuKaren Suchanek Hudmon Original Research Article Open access 09 June 2021 Pages: 649 - 653
Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia Yared Belete BelayEskinder Eshetu AliBeate Sander Original Research Article Open access 16 June 2021 Pages: 655 - 664
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study David J. MottIain LeslieNicolas Scheuer Original Research Article Open access 09 May 2021 Pages: 665 - 675
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK T. Alexander Russell-SmithJames BrockbankChristopher Knight Original Research Article Open access 28 June 2021 Pages: 677 - 691
Cost-Effectiveness of Peer-Educator–Delivered Lifestyle Modification for Type 2 Diabetes Prevention in a Young Healthy Population in Sri Lanka: A Trial-Based Economic Evaluation and Economic Model James ShearerMiral KalyaniJanaka Karalliedde Original Research Article Open access 12 July 2021 Pages: 693 - 700
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making Jason GordonAngela StainthorpeJohn Borrill Original Research Article Open access 02 July 2021 Pages: 701 - 713
Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities Ioana-Alexandra SoareOscar LeeuwenkampLouise Longworth Original Research Article Open access 14 July 2021 Pages: 715 - 725
The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US Satabdi ChatterjeeDavid WalkerRajender R. Aparasu Original Research Article Open access 13 July 2021 Pages: 727 - 736
Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies Edward C. F. WilsonAlice WrefordVincent J. Gnanapragasam Original Research Article Open access 09 July 2021 Pages: 737 - 753
Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast Nigeria Maduka Donatus UghasoroJames Onuorah AkpehObinna Emmanuel Onwujekwe Original Research Article Open access 08 April 2021 Pages: 755 - 764
Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective Nan QiaoRalph InsingaGilberto Lopes Original Research Article Open access 22 July 2021 Pages: 765 - 778